- PLN22.33m
- PLN23.15m
- PLN1.71m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 16.41 | ||
| Price to Tang. Book | 16.62 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 13.07 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -81.49% | ||
| Return on Equity | -276.53% | ||
| Operating Margin | -355.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 0.41 | 0.37 | 0.65 | 1.87 | 1.71 | n/a | n/a | 70.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nestmedic SA is a Poland-based company engaged in the manufacture of medical diagnostic equipment. The Company focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures mother’s pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.
Directors
- Jacek Gnich CMG
- Beata Turlejska-Zdunczyk VSU
- Magdalena Baron SUB
- Armin Burckhardt SUB
- Kamil Gorzelnik SUB
- Karol Hop SUB
- Marzena Mazurek SUB
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 28th, 2017
- Public Since
- June 12th, 2017
- No. of Employees
- 9
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Warsaw Stock Exchange- Shares in Issue
- 27,500,404
- Address
- ul. Pasymska 20, WARSZAWA, 01-993
- Web
- https://nestmedic.com/
- Phone
- +48 717575708
- Auditors
- WBS Audyt Sp. z o.o.
Upcoming Events for NST
Similar to NST
CM International SA
Warsaw Stock Exchange
Inventionmed SA
Warsaw Stock Exchange
Massmedica SA
Warsaw Stock Exchange
Medicalgorithmics SA
Warsaw Stock Exchange
Medinice SA
Warsaw Stock Exchange
FAQ
As of Today at 19:15 UTC, shares in Nestmedic SA are trading at PLN0.81. This share price information is delayed by 15 minutes.
Shares in Nestmedic SA last closed at PLN0.81 and the price had moved by -52.79% over the past 365 days. In terms of relative price strength the Nestmedic SA share price has underperformed the FTSE Global All Cap Index by -55.68% over the past year.
There is no consensus recommendation for this security.
Nestmedic SA does not currently pay a dividend.
Nestmedic SA does not currently pay a dividend.
Nestmedic SA does not currently pay a dividend.
To buy shares in Nestmedic SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN0.81, shares in Nestmedic SA had a market capitalisation of PLN22.33m.
Here are the trading details for Nestmedic SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: NST
Based on an overall assessment of its quality, value and momentum Nestmedic SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nestmedic SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -47.29%.
As of the last closing price of PLN0.81, shares in Nestmedic SA were trading -39.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nestmedic SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN0.81.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Nestmedic SA's management team is headed by:
- Jacek Gnich - CMG
- Beata Turlejska-Zdunczyk - VSU
- Magdalena Baron - SUB
- Armin Burckhardt - SUB
- Kamil Gorzelnik - SUB
- Karol Hop - SUB
- Marzena Mazurek - SUB